GE
George A Eldridge
See Remarks

George A Eldridge insider trades: Aerovate Therapeutics (AVTE) stock sales

See Remarks, Aerovate Therapeutics Last trade Jun 14, 2024 15 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
10
Open-market trades
since 2022
2
Companies
last trade 2024

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where George reports to the SEC

Open-market buys and sales

10 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jun 14, 2024AVTE↓ Sell$375K
Apr 10, 2024AVTE↓ Sell$201K
Apr 1, 2024AVTE↓ Sell$390K
Mar 13, 2024AVTE↓ Sell$102K
Mar 11, 2024AVTE↓ Sell$649K
Dec 12, 2022AVTE↓ Sell$397K
Dec 8, 2022AVTE↓ Sell$517K
Nov 30, 2022AVTE↓ Sell$2K
Nov 23, 2022AVTE↓ Sell$24K
Nov 22, 2022AVTE↓ Sell$20K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About George A Eldridge's insider trades

George A Eldridge is See Remarks at Aerovate Therapeutics (AVTE). Since Nov 22, 2022, George has reported no open-market purchases and 10 sales worth $2.7M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include option exercises (10 filings), grants and awards (5 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AVTE insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.